Timothy Kelly serves as the Chief Financial Officer at PRAXIS PRECISION MEDICINES INC, a position he has held since joining the company in 2021. With over 20 years of experience in the finance and biotechnology sectors, Kelly has established himself as a seasoned executive with a keen understanding of the industry's financial dynamics. Prior to his role at PRAXIS, he held significant positions at several prominent companies, including CFO at Akebia Therapeutics, where he played a pivotal role in guiding the company through its IPO and subsequent growth phases. Kelly's professional journey is marked by a series of notable achievements that underscore his expertise and leadership. At Akebia Therapeutics, he was instrumental in securing substantial funding and navigating complex financial landscapes, which contributed to the company's successful market expansion. His strategic vision and ability to manage financial operations have been critical in driving growth and innovation at the companies he has served. Kelly's educational background, with a Bachelor's degree in Business Administration from Boston University and an MBA from Harvard Business School, has provided him with a solid foundation to excel in his roles. In his current position at PRAXIS PRECISION MEDICINES INC, Timothy Kelly is responsible for overseeing the company's financial strategy, which includes managing budgets, financial planning, and investor relations. His role is crucial in ensuring that PRAXIS remains financially robust as it advances its mission to develop precision medicines for central nervous system disorders. Under his stewardship, the company has continued to make significant strides in its research and development efforts, positioning itself as a leader in the field of precision medicine. Kelly's leadership and financial acumen are key assets that continue to drive PRAXIS towards achieving its long-term objectives.